Organon & Co. (OGN)
13.92
+0.02
(+0.14%)
USD |
NYSE |
Nov 18, 16:00
13.92
0.00 (0.00%)
After-Hours: 20:00
Organon Price : 13.92 for Nov. 18, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 17, 2026 | 13.90 | 13.91 | 13.89 | 13.90 | 4.164M |
| Nov 16, 2026 | 13.88 | 13.91 | 13.88 | 13.90 | 3.534M |
| Nov 13, 2026 | 13.90 | 13.90 | 13.88 | 13.90 | 3.999M |
| Nov 12, 2026 | 13.87 | 13.90 | 13.87 | 13.90 | 2.904M |
| Nov 11, 2026 | 13.89 | 13.89 | 13.86 | 13.89 | 1.871M |
| Nov 10, 2026 | 13.83 | 13.89 | 13.83 | 13.89 | 2.356M |
| Nov 09, 2026 | 13.87 | 13.88 | 13.82 | 13.85 | 2.985M |
| Nov 06, 2026 | 13.80 | 13.87 | 13.78 | 13.87 | 3.947M |
| Nov 05, 2026 | 13.86 | 13.86 | 13.79 | 13.79 | 3.756M |
| Nov 04, 2026 | 13.83 | 13.88 | 13.83 | 13.83 | 2.648M |
| Nov 03, 2026 | 13.83 | 13.85 | 13.82 | 13.85 | 3.658M |
| Nov 02, 2026 | 13.85 | 13.85 | 13.82 | 13.82 | 2.147M |
| Oct 30, 2026 | 13.83 | 13.84 | 13.80 | 13.84 | 1.848M |
| Oct 29, 2026 | 13.76 | 13.83 | 13.76 | 13.81 | 2.510M |
| Oct 28, 2026 | 13.75 | 13.78 | 13.75 | 13.78 | 3.163M |
| Oct 27, 2026 | 13.74 | 13.78 | 13.74 | 13.75 | 1.865M |
| Oct 26, 2026 | 13.75 | 13.76 | 13.74 | 13.74 | 1.548M |
| Oct 23, 2026 | 13.74 | 13.76 | 13.74 | 13.75 | 1.054M |
| Oct 22, 2026 | 13.75 | 13.76 | 13.74 | 13.75 | 2.554M |
| Oct 21, 2026 | 13.75 | 13.77 | 13.74 | 13.75 | 2.556M |
| Oct 20, 2026 | 13.75 | 13.80 | 13.74 | 13.76 | 2.550M |
| Oct 19, 2026 | 13.77 | 13.77 | 13.72 | 13.75 | 3.254M |
| Oct 16, 2026 | 13.77 | 13.78 | 13.74 | 13.76 | 2.647M |
| Oct 15, 2026 | 13.75 | 13.77 | 13.75 | 13.76 | 1.980M |
| Oct 14, 2026 | 13.77 | 13.77 | 13.74 | 13.74 | 1.808M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Viatris, Inc. | 20.28 |
| Pacira Biosciences, Inc. | 36.48 |
| ANI Pharmaceuticals, Inc. | 69.47 |
| Corcept Therapeutics, Inc. | 67.72 |
| Veru, Inc. | 2.31 |
Price Related Metrics
| PE Ratio | 18.10 |
| PS Ratio | 0.6082 |
| Price to Book Value | 3.064 |
| Price to Free Cash Flow | 5.047 |
| Earnings Yield | 5.52% |
| Market Cap | 3.656B |
| Operating PE Ratio | 3.101 |
| Normalized PE Ratio | 9.585 |